Advertisement
Screener

TransMedics Group, Inc. (TMDX) Graph

TMDX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $189.95M; Cost of revenue $76.75M; Research and development $31.63M; Selling, general and administrative $57.83M.
  • 2026-03-31: Revenue $173.93M; Cost of revenue $72.77M; Research and development $24.88M; Selling, general and administrative $62.98M.
  • 2025-12-31: Revenue $160.76M*; Cost of revenue $67.35M*; Research and development $20.70M*; Selling, general and administrative $51.44M*.
  • 2025-09-30: Revenue $143.82M; Cost of revenue $59.25M; Research and development $15.26M; Selling, general and administrative $46.02M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

TMDX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$111.16MService$78.79MService UnrelatedTo OCS Transplant$1.00MRevenue$189.95MCost of revenue$76.75MGross profit$113.20MOperating expenses$89.46MOperating income$23.74MResearch & development$31.63MSelling, general& administrative$57.83MPre-tax income$19.40MNet income$14.68M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

TMDX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Ocs Transplant Revenue$188.86MRevenue$189.95MCost of revenue$76.75MGross profit$113.20MOperating expenses$89.46MOperating income$23.74MResearch & development$31.63MSelling, general& administrative$57.83MPre-tax income$19.40MNet income$14.68M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$189.95M$76.75M$31.63M$57.83M$89.46M$4.72M$14.68M
2026-03-31$173.93M$72.77M$24.88M$62.98M$87.86M$1.17M$7.32M
2025-12-31$160.76M*$67.35M*$20.70M*$51.44M*$72.14M*-$83.75M*$105.39M*
2025-09-30$143.82M$59.25M$15.26M$46.02M$61.27M-$1.29M$24.32M
2025-06-30$157.37M$60.78M$15.93M$44.09M$60.02M$1.27M$34.91M
2025-03-31$143.54M$55.31M$17.16M$43.63M$60.78M$994.00K$25.68M
2024-09-30$108.76M$47.92M$14.27M$42.66M$56.92M$29.00K$4.22M
2024-06-30$114.31M$45.04M$13.86M$42.90M$56.75M-$41.00K$12.19M
2024-03-31$96.85M$36.89M$11.38M$36.16M$47.54M$196.00K$12.20M
2023-09-30$66.43M$25.77M$11.13M$30.65M$69.00M(m)-$25.42M
2023-06-30$52.47M$15.72M$8.29M$29.36M$37.65M(m)-$1.00M
2023-03-31$41.55M$12.79M$5.87M$24.98M$30.86M(m)-$2.64M
2022-09-30$25.68M$7.57M$6.81M$16.85M$23.66M(m)-$7.43M
2022-06-30$20.52M$6.17M$6.71M$17.38M$24.09M(m)-$11.52M
2022-03-31$15.88M$3.78M$7.53M$13.94M$21.47M(m)-$10.56M
2021-09-30(m)$1.60M$5.16M$10.34M$15.50M(m)-$12.96M
2021-06-30(m)$2.58M$6.29M$9.16M$15.46M(m)-$10.67M
2021-03-31(m)$2.24M$4.53M$6.79M$11.32M(m)-$7.92M
2020-12-31$7.63M(m)(m)(m)(m)(m)-$6.31M
2020-09-30(m)$2.05M$4.16M$5.49M$9.65M(m)-$5.09M
2020-06-30(m)$1.48M$3.90M$5.87M$9.77M(m)-$8.50M
2020-03-31(m)$2.67M$6.22M$6.65M$12.88M(m)-$8.85M
2019-12-28$6.06M(m)(m)(m)(m)(m)-$9.18M
2019-09-28$7.21M$2.99M$4.94M$6.52M$11.46M(m)-$8.28M
2019-06-29$5.67M$2.33M$4.79M$6.25M$11.04M(m)-$9.20M
2019-03-30$4.68M$2.10M$3.88M$4.65M$8.54M(m)-$6.89M
2019-03-29(m)(m)(m)(m)(m)(m)-$6.89M
2018-12-29$3.54M(m)(m)(m)(m)(m)-$7.63M
2018-09-29$4.04M$1.91M$3.27M$2.80M$6.07M(m)-$5.11M
2018-06-30$2.92M$1.74M$3.43M$2.90M$6.33M(m)-$6.12M
2018-03-31$2.52M$1.59M$3.46M$2.24M$5.71M(m)-$4.90M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$363.88M$149.52M$56.51M$120.81M$177.33M$5.89M$22.00M
2025-06-30$300.91M$116.09M$33.09M$87.71M$120.81M$2.27M$60.59M
2024-06-30$211.16M$81.93M$25.24M$79.06M$104.29M$155.00K$24.39M
2023-06-30$94.02M$28.51M$14.16M$54.34M$68.50M(m)-$3.64M
2022-06-30$36.40M$9.95M$14.25M$31.32M$45.57M(m)-$22.09M
2021-06-30(m)$4.82M$10.83M$15.95M$26.77M(m)-$18.59M
2020-06-30(m)$4.15M$10.13M$12.52M$22.65M(m)-$17.35M
2019-06-29(m)$4.44M$8.67M$10.90M$19.57M(m)-$16.09M
2018-06-30(m)$3.33M$6.90M$5.14M$12.04M(m)-$11.02M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$444.73M$175.34M$48.35M$133.73M$182.08M$981.00K$84.91M
2024-09-30$319.92M$129.85M$39.50M$121.71M$161.22M$184.00K$28.61M
2023-09-30$160.45M$54.28M$25.29M$84.99M$137.50M(m)-$29.06M
2022-09-30$62.08M$17.52M$21.06M$48.17M$69.23M(m)-$29.51M
2021-09-30(m)$6.42M$15.99M$26.28M$42.27M(m)-$31.55M
2020-09-30(m)$6.21M$14.28M$18.01M$32.30M(m)-$22.44M
2019-09-28(m)$7.42M$13.61M$17.42M$31.03M(m)-$24.37M
2018-09-29(m)$5.24M$10.17M$7.94M$18.11M(m)-$16.12M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$605.49M$242.69M$69.06M$185.17M$254.22M-$82.77M$190.30M
2024-12-31$441.54M$179.46M$55.97M$168.62M$224.59M$316.00K$35.50M
2023-12-31$241.62M$87.53M$36.05M$119.55M$182.82M-$1.64M-$25.00M
2022-12-31$93.46M$28.19M$26.81M$69.90M$96.71M$66.00K-$36.20M
2021-12-31$30.26M$9.10M$22.30M$38.28M$60.59M(m)-$44.20M
2020-12-31$25.64M$9.00M$18.83M$24.19M$43.02M$0.00-$28.75M
2019-12-28(m)$9.74M$19.87M$23.60M$43.47M$0.00-$33.55M
2018-12-29(m)$7.28M$13.66M$12.31M$25.97M$0.00-$23.76M
2017-12-30(m)(m)(m)(m)(m)$0.00(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53